Suppr超能文献

用于持续药物递送的丝质储库植入物。

Silk reservoir implants for sustained drug delivery.

作者信息

Wolfe Alexander J, Guasto Jeffrey S, Omenetto Fiorenzo G, Kaplan David L

机构信息

Department of Biomedical Engineering, Tufts University, 200 College Avenue, Medford, Massachusetts 02155.

Department of Mechanical Engineering, Tufts University, 200 College Avenue, Medford, Massachusetts 02155.

出版信息

ACS Appl Bio Mater. 2021 Jan 18;4(1):869-880. doi: 10.1021/acsabm.0c01382. Epub 2021 Jan 6.

Abstract

Biomaterial implants for the sustained delivery of therapeutics can be utilized to deliver drugs at near-constant rates over extended time frames to provide an alternative to daily oral medications. The biomaterials used to construct these systems, however, are often not bioresorbable and thus require a secondary surgery for removal from the body, and fabrication of these systems may require the use of harsh chemical solvents. To address these shortcomings, a fabrication process was developed to generate biodegradable drug reservoir systems from regenerated silk fibroin protein solution (23% w/v). The tubular systems, with an inner diameter of 2.0 mm and wall thickness < 250µm, were developed using an all-aqueous solution-gel-solid phase transition curing process. Two different clinically-relevant therapeutics were released at near-constant rates for 30 days (> 100µg/day). The protein secondary structure of the devices consisted of 40% crystalline beta sheet. Mechanically, radial compression (1mm/min) of unloaded systems demonstrated Young's moduli similar to cancellous (spongy) bone (100 to 250 MPa) and the systems showed good recovery under cyclic compression (to 17.5% strain). The devices could be generated in complex shapes (e.g., hollow cylinders) via an additive molding process, offering the potential for drug delivery but also for broader applications in tissue engineering and diagnostics.

摘要

用于持续递送治疗剂的生物材料植入物可用于在较长时间内以接近恒定的速率递送药物,从而为每日口服药物提供替代方案。然而,用于构建这些系统的生物材料通常不可生物吸收,因此需要进行二次手术以从体内取出,并且这些系统的制造可能需要使用苛刻的化学溶剂。为了解决这些缺点,开发了一种制造工艺,以从再生丝素蛋白溶液(23% w/v)中生成可生物降解的药物储库系统。使用全水溶液-凝胶-固相转变固化工艺开发了内径为2.0毫米且壁厚<250微米的管状系统。两种不同的临床相关治疗剂以接近恒定的速率释放30天(>100微克/天)。该装置的蛋白质二级结构由40%的结晶β片层组成。在力学方面,未加载系统的径向压缩(1毫米/分钟)显示出与松质(海绵状)骨相似的杨氏模量(100至250兆帕),并且该系统在循环压缩(至17.5%应变)下显示出良好的恢复能力。这些装置可以通过增材成型工艺制成复杂形状(例如空心圆柱体),不仅为药物递送提供了潜力,也为组织工程和诊断中的更广泛应用提供了潜力。

相似文献

1
Silk reservoir implants for sustained drug delivery.用于持续药物递送的丝质储库植入物。
ACS Appl Bio Mater. 2021 Jan 18;4(1):869-880. doi: 10.1021/acsabm.0c01382. Epub 2021 Jan 6.
2
Silk fibroin rods for sustained delivery of breast cancer therapeutics.丝素纤维棒用于持续递送乳腺癌治疗药物。
Biomaterials. 2014 Oct;35(30):8613-20. doi: 10.1016/j.biomaterials.2014.06.030. Epub 2014 Jul 6.
3
Silk fibroin encapsulated powder reservoirs for sustained release of adenosine.丝素蛋白包封粉末储库用于持续释放腺苷。
J Control Release. 2010 Jun 1;144(2):159-67. doi: 10.1016/j.jconrel.2010.01.035. Epub 2010 Feb 6.
9
Structure and properties of regenerated Antheraea pernyi silk fibroin in aqueous solution.水溶液中再生柞蚕丝素蛋白的结构与性能
Int J Biol Macromol. 2007 Apr 10;40(5):472-8. doi: 10.1016/j.ijbiomac.2006.11.006. Epub 2006 Nov 24.
10
Silk fibroin biomaterials for controlled release drug delivery.丝素蛋白生物材料用于控制药物释放。
Expert Opin Drug Deliv. 2011 Jun;8(6):797-811. doi: 10.1517/17425247.2011.568936. Epub 2011 Apr 1.

本文引用的文献

4
Modulation of vincristine and doxorubicin binding and release from silk films.长春新碱和阿霉素与丝素膜结合及释放的调控
J Control Release. 2015 Dec 28;220(Pt A):229-238. doi: 10.1016/j.jconrel.2015.10.035. Epub 2015 Oct 21.
8
Highly tunable elastomeric silk biomaterials.高度可调谐的弹性丝生物材料。
Adv Funct Mater. 2014 Aug 6;24(29):4615-4624. doi: 10.1002/adfm.201400526.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验